Compare GAIA & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GAIA | ECOR |
|---|---|---|
| Founded | 1988 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.9M | 81.0M |
| IPO Year | 1999 | 2018 |
| Metric | GAIA | ECOR |
|---|---|---|
| Price | $2.56 | $10.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.50 | ★ $18.00 |
| AVG Volume (30 Days) | 85.0K | ★ 171.3K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.18 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,500,000.00 | ★ $32,032,000.00 |
| Revenue This Year | $13.07 | $33.60 |
| Revenue Next Year | $12.04 | $30.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 12.50 | ★ 27.20 |
| 52 Week Low | $2.23 | $4.16 |
| 52 Week High | $6.39 | $10.40 |
| Indicator | GAIA | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 51.01 | 65.94 |
| Support Level | $2.45 | $4.92 |
| Resistance Level | $2.60 | $10.37 |
| Average True Range (ATR) | 0.13 | 1.16 |
| MACD | 0.04 | 0.08 |
| Stochastic Oscillator | 59.62 | 93.88 |
Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.